Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

401
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

502
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
502
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

722
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
722
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

453
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
453

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Alterations of right ventricular assessment by use of an ultrasound-enhancing agent during routine visualization of the left ventricle.

European heart journal. Imaging methods and practice·2026
Same author

Multimodality imaging of patent ductus arteriosus with severe pulmonary hypertension following 3 pregnancies.

Radiology case reports·2026
Same author

Bioinformatics and AI/ML approaches using multi-omics data to accelerate diagnosis and delivery of precision care for patients with rare diseases.

Methods in cell biology·2026
Same author

A Case Series of Trileaflet Mitral Valves.

CASE (Philadelphia, Pa.)·2026
Same author

Cardiovascular Computed Tomography Angiographic Assessment of Simple Cardiac Shunts in Adults.

Reviews in cardiovascular medicine·2025
Same author

Strategic Approach Towards the Evaluation of HeartMate 3 Left Ventricular Assist Devices Using Multimodality Imaging.

The American journal of cardiology·2025

相关实验视频

Updated: Jan 15, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.2K

超性心肌病:当前的前景

Dhruvil Patel1, Ruchika Bhargav1, Aliaa Mousa1

  • 1Department of Cardiology, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ 08901, USA.

Reviews in cardiovascular medicine
|October 15, 2025
PubMed
概括

增高性心肌病变 (HCM) 是一种遗传性心脏病,每200-500人中就有1人患有这种疾病. 这篇评论探讨了它的遗传基础,通过成像诊断,以及超越传统治疗的新疗法.

科学领域:

  • 心脏病学 心脏病学
  • 遗传学 是一个遗传学.
  • 病理生理学 病理生理学

背景情况:

  • 增高性心肌病变 (HCM) 是一种遗传性疾病,导致左心室增高 (LVH).
  • 患病率估计范围从每200人中的1人到每500人中的1人.
  • 目前正在进行的研究确定了新的突变和病理生理机制.

研究的目的:

  • 系统地审查HCM的遗传和病理生理基础.
  • 探索多模式成像在诊断和风险分层HCM患者中的作用.
  • 检查当代的管理策略和新的治疗方法对HCM.

主要方法:

  • 关于HCM的遗传和病理生理学研究的文献综述.
  • 分析用于HCM诊断和风险分层的多模式成像技术.
  • 检查当前和新兴的治疗策略对HCM.

主要成果:

  • 已经确定了许多与HCM相关的致病突变.
  • 多模式成像对于准确的诊断和风险分层至关重要.
  • 针对分子机制的新疗法为治疗提供了新的途径.

结论:

关键词:
一个有趣的东西.酒精隔膜移除 酒精隔膜移除过度缩性心肌病变性心脏病.我不应该这样做了.突然的心脏病死亡.这是一种手术性肌肉切除术.

更多相关视频

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.2K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.6K

相关实验视频

Last Updated: Jan 15, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.2K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.2K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.6K
  • 人们对HCM的理解已经进化,导致了更精细的定义和认可.
  • 先进的成像和遗传洞察力改善了患者管理.
  • 新兴的向疗法为传统干预措施提供了替代方案,如肌切除术或隔膜切除.